Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), a leader in innovative drug development and a vocal advocate for reducing unnecessary animal testing, today voiced serious concerns over the U.S.
Objectives Chronic exertional compartment syndrome (CECS) is traditionally confirmed by intracompartmental pressure (ICP) measurement, but this test has been criticised. The aim of this study was to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results